"Serum neurogranin measurement as a biomarker of acute traumatic brain injury. Clin Biochem."Clin Biochem. 48(0): 843–848, 2015.


Jun Yang, Frederick K. Korley, Min Dai, Allen D. Everett.

Conclusion:

We have developed a highly sensitive and reproducible ELISA for measuring circulating NRGN in blood samples. Serum NRGN concentrations in acute TBI patients were significantly higher than in controls, indicating that NRGN could have utility as a circulating biomarker for acute TBI. This report provides evidence to support larger and controlled TBI clinical studies for NRGN validation and prediction of outcomes.